[1]Kirkali Z, Tuzel E, Mungan MU.Recent advances in kidney cancer and metastatic disease[J].BJU Int,2001,88(8):818-[2] Ljungberg B, Hanbury DC, Kuczyk MA, et al.Renal cell carcinoma guideline[J].Eur Urol,2007,51(1502):1510-[3]Bleumer I.nullOosterwijk E ,De Mulder P ,et al . Immunotherapy for renal cell carcinoma[J].. Eur Urol,2003,:-[4]Hein Van Poppel, Steven Joniau, Stefaan W,Van Gool. Vaccine Therapy in Patients with Renal Cell Carcinoma.[J].European Urology,2009,55(6):1333-1344[5] 李科,李君武,苏泽轩,刘艳.肾癌G25基因和hGM-CSF基因双顺反子表达质粒的构建及鉴定[J].中国现代医学杂志,2009,19(8):1176-1182[6] Potter CP, HarrisAL, Diagnostic.Prognostic and Therapeutic implications on carbonic anhydrases in cancer[J].Br J Cancer,2003,89(1):2-7[7]Opavsky R, Pastorekova S, Zeinik V, et al.Gene, a novel member of the carbinic angydase familu:structure and exon toprotein domain relationships[J].Genomics,1996,33(3):480-[8]Oosterwijk E, Ruiter DJ , Hoedemaker PJ , et al.Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney[J].Int J Cancer,1986,38(4):489-[9] Vissers JL, De Vries IJ, Schreurs MW, et al.The renal cell carci-noma-associated antigen G250 encodes a human leukocyte antigen (HLA) -A2. 1-restricted epitope recognized by cytotoxic T lymphocytes[J].Cancer Res,1999,59(21):5554-5559[10]Dorai T, Sawczuk IS, Pastorek J , et al.The role of carbonic anhydrase IX overexpression in kidney cancer[J].Eur J Cancer,2005,41(18):2935-2947[11] Cruciani M, Mengoli C, Serpelloni G, Mazzi R, Bosco O, Malena M.Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis [J].Vaccine,2007,25(4):709-718[12] Miyashita T, Shah FA, Marti G, Wang J, Armstrong T, Bonde P, Gibson MK, Yoshimura K, Montgomery EA, Duncan MD, Jaffee EM, Harmon JW.Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting[J].Gastrointest Surg,2008 ,12(1):2-9[13]Hongmei Chen,Xuefan Bai.Gene adjuvant of DNA vaccine[J].Foreign Medical Sciences Section of Immunology,2004,27(6):350-353[14]Meyer RG, Korn S, Micke P, Becker K, Huber C, W?lfel T, Buhl R.An open-label, prospective phase Ⅰ/Ⅱ study evaluating the immuno- genicity and safety of a raspeptide vaccine plus GM-CSF in patients with non-small cell lung cancer[J].Lung Cancer,2007,58(1):88-94[15] Toubaji A, Hill S, Terabe M, Qian J, Floyd T, Simpson RM,et al.Simpson RM,et al. The combination of
GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides
long term tumor protection[J].Vaccine,2007,25(31):5882-5891[16]Yanru Lu,Zhenyou Jiang.Construction and Expression of Eukaryotic Expression Vector Containing Human GM-CSF Gene[J].Journal of Sun Yat-sen University,2009,28(5):590-598 |